These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10155297)

  • 1. Cost effectiveness of roxithromycin versus cefaclor in Australia.
    Scott WG; Cooper BC; Scott HM; Tilyard MW; Dovey SM
    Pharmacoeconomics; 1995 Jan; 7(1):93-4. PubMed ID: 10155297
    [No Abstract]   [Full Text] [Related]  

  • 2. Roxithromycin vs cefaclor.
    Hughes T; Scott WG; Scott HM
    Pharmacoeconomics; 1993 Nov; 4(5):396-8. PubMed ID: 10146876
    [No Abstract]   [Full Text] [Related]  

  • 3. Roxithromycin versus cefaclor in lower respiratory tract infection: a general practice pharmacoeconomic study.
    Scott WG; Tilyard MW; Dovey SM; Cooper B; Scott HM
    Pharmacoeconomics; 1993 Aug; 4(2):122-30. PubMed ID: 10146972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomic evaluation of roxithromycin versus amoxycillin/clavulanic acid in a community-acquired lower respiratory tract infection study.
    Scott WG; Cooper BC; Scott HM
    Infection; 1995; 23 Suppl 1():S21-4. PubMed ID: 7782111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roxithromycin and lower respiratory tract infections.
    Scott WG; Cooper BC; Scott HM; Karalus NC; Garrett J; Lang SD
    N Z Med J; 1994 May; 107(978):208. PubMed ID: 7980759
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic analysis of treatment with roxithromycin in comparison with erythromycin in patients with lower respiratory tract infections.
    Norinder A; Paulsen O; Hjortsberg C
    Scand J Infect Dis; 1997; 29(1):83-6. PubMed ID: 9112304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy-enforced outpatient drug treatment protocols: a case study of Medi-Cal restrictions for cefaclor.
    McCombs JS; Nichol MB
    Ann Pharmacother; 1993 Feb; 27(2):155-61. PubMed ID: 8439688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerance of roxithromycin in comparison with erythromycin stearate in patients with lower respiratory tract infections.
    Paulsen O; Christensson BA; Hebelka M; Ljungberg B; Nilsson-Ehle I; Nyman L; Svensson R; Tüll P; Varga Z
    Scand J Infect Dis; 1992; 24(2):219-25. PubMed ID: 1641600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.
    Markham A; Faulds D
    Drugs; 1994 Aug; 48(2):297-326. PubMed ID: 7527329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of roxithromycin in respiratory tract infections.
    Ludwig E; Graber H; Bárándy Z; Lányi
    J Chemother; 1989 Jul; 1(4 Suppl):796-7. PubMed ID: 16312644
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of and tolerance to azithromycin versus roxithromycin in the treatment of patients with acute infections of the upper respiratory tract].
    Bosatra A; Tattoni P; Podda M; Pirodda E; Buccolieri M; Amorosa L
    Clin Ter; 1994 Jan; 144(1):27-30. PubMed ID: 8168348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cefaclor in the treatment of respiratory tract infections in children].
    Klech H; Stur O; Götz M
    Padiatr Padol; 1985; 20(3):297-306. PubMed ID: 4034220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefaclor in the treatment of lower respiratory tract infections: a review.
    Brown RB
    Clin Ther; 1988; 11 Suppl A():54-65. PubMed ID: 3072087
    [No Abstract]   [Full Text] [Related]  

  • 14. Roxithromycin vs amoxycillin/clavulanic acid in lower respiratory tract infections.
    Brett W
    N Z Med J; 1994 Aug; 107(983):319-20. PubMed ID: 8052477
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
    Leveque B; Lambert-Zechovsky N; Cathlin C
    Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the safety and efficacy of cefuroxime axetil and cefaclor in outpatient management of community-acquired lower respiratory tract infections.
    Nolen TM; Hutchison J; Phillips HL
    J Chemother; 1989 Jul; 1(4 Suppl):768-9. PubMed ID: 16312631
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of roxithromycin in the treatment of lower respiratory tract infections in patients with chronic respiratory disease].
    Marcos Sánchez F; Celdrán Gil J; Llorente Domingo P; Durán Pérez-Navarro A
    An Med Interna; 1991 Jun; 8(6):312-3. PubMed ID: 1888851
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of lower respiratory tract infections with cefuroxime-axetil. Comparison with cefaclor].
    Pariente R; Rochemaure J; Murciano D; Brechot JM; Pappo M
    Therapie; 1988; 43 Suppl 4():361-4. PubMed ID: 3222777
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind study comparing cefaclor and amoxycillin in the treatment of respiratory tract infections in general practice.
    Brodie NH; McGhie RL; O'Hara H; O'Hara J; Rahman MK; Vallé-Jones JC
    Pharmatherapeutica; 1980; 2(7):494-8. PubMed ID: 7010383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Respiratory infections: germs sensitive to cefaclor].
    Ann Pediatr (Paris); 1992 May; 39(5):300. PubMed ID: 1616246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.